SPONSOR
University Hospital Schleswig-Holstein
Total Trials
3
Recruiting
3
Phases
Phase 4
University Hospital Schleswig-Holstein is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Ulcerative Colitis (UC), COVID-19, Breast Cancer Female.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital Schleswig-Holstein
How many clinical trials has University Hospital Schleswig-Holstein sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by University Hospital Schleswig-Holstein, of which 3 are actively recruiting participants. These trials cover conditions including Ulcerative Colitis (UC), COVID-19, Breast Cancer Female. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital Schleswig-Holstein research focus on?
University Hospital Schleswig-Holstein clinical trials span Ulcerative Colitis (UC), COVID-19, Breast Cancer Female. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital Schleswig-Holstein clinical trial?
To participate in a University Hospital Schleswig-Holstein trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital Schleswig-Holstein trials with current recruitment status updated daily.
Clinical Trials by University Hospital Schleswig-Holstein
NCT07235904 Phase 4
Recruiting
Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis
Ulcerative Colitis (UC)
NCT04679584
Recruiting
COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life
COVID-19
NCT06483477
Recruiting
Dermatitis During Adjuvant Irradiation for BREAst Cancer:
Breast Cancer Female
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology